A B S T R A C T Two patients with severe postural hypotension associated with upper motor neuron and cerebellar impairment (Shy-Drager syndrome) have been studied. Head-up tilt and lower body negative pressure application caused marked falls in arterial pressure; in one patient, paradoxical vasodilatation was observed. Ice application did not increase arterial pressure or calculated forearm vascular resistance. Intravenous atropine in one patient increased heart rate by 18 beats per min, a cardioacceleratory response similar to exhausting recumbent exercise in that patient. 24 hr urinary catecholamine excretion was low, but aldosterone secretory rate was normal in the more severely afflicted patient. A prolonged elevation of plasma renin activity was noted when post-tilt hypertension occurred. When head-up tilt was not followed by this hypertensive period, plasma renin activity response to tilting was normal. Intraarterial norepinephrine and tyramine both elicited a vasoconstrictor response. Intra-arterial infusions of norepinephrine and tyramine were repeated after administration of the monoamine oxidase inhibitor tranylcypromine. Norepinephrine was potentiated 4.1-and 0.5-fold in the two patients; tyramine was potentiated 3.7-and 1.1-fold in the two patients, respectively. A therapeutic program of tranylcypromine and tyramine (in the form of cheddar cheese) resulted in substantial clinical improvement. It is concluded that in at least some patients with idiopathic postural hypotension, norepinephrine is present in postganglionic sympathetic fibers. A therapeutic program of tyramine and a monoamine oxiThis work was presented in part at
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This study was performed during Dr. Diamond's tenure as a Public Health Service Fellow.
INTRODUCTION
Although impaired arteriolar and venous constriction has been noted in idiopathic postural hypotension, the exact mechanism responsible has not been elucidated (2) (3) (4) (5) (6) . This report studies the pathophysiologic mechanism related to impaired vasoconstriction, and further describes a new mode of therapy.
METHODS
Two men, aged 45 and 49, with idiopathic postural hypotension have been studied. Both patients were strikingly similar in regard to historical features, progressioii of disease, physical examination, physiologic testing, and finally, response to therapy. In both, there was a 4 yr history of anhydrosis, impotence, urinary incontinence, constipation, postural hypotension, and incoordination. Physical examination demonstrated the severe postural hypotension as well as upper motor neuron and cerebellar damage, suggesting that they fit into the clinically recognized Shy-Drager variant of this syndrome (7, 8) . Unsuccessful earlier therapy in both patients had included mineralocorticoids, sympathomimetic amines, Jobst pressure garments, and high salt intake. Up to 1 mg/day of 9-a-fluorohydrocortisone was given to the patients. In both, marked peripheral edema was noted without any significant lessening of orthostatic hypotension. The older patient, W. L., was so incapacitated by his orthostatic hypotension that he had been essentially bedridden for 1 yr prior to the present study. Patient C. H. could sit without apparent difficulty, but standing evoked syncope.
Reproducible study conditions were assured by constant supervision on the Metabolic Research Ward where a measured 4 g sodium diet was given during testing procedures. Throughout the period of study, careful monitoring of activity, blood pressure, and heart rate was achieved.
24 hr urinary epinephrine and norepinephrine excretion was measured utilizing a fluorometric technique (9) .1 Plasma renin activity response to head-up tilting was performed after 12 hr of recumbency, by the method of Helmer and Judson (10) . 24 hr aldosterone secretory rate was determined in a constant temperature ward after the patient had received a diet containing 43.5 mEq of sodium per day for 5 days. The patient then received 2 liters of normal saline from 10 a.m. to 2 p.m. on each of 2 successive days. Aldosterone secretory rates were measured on the day before saline infusion and on the second infusion day. The method of Kliman and Peterson was followed (11) .
The test procedures were designed to determine the degree of orthostatic impairment and the functional integrity of the adrenergic nervous system. In all tests, heart rate was determined from a continuously running electrocardiogram. Blood pressure was recorded by means of an indwelling arterial catheter placed in the subclavian artery by means of a percutaneous brachial artery puncture, or by the cuffauscultatory method; both techniques for measuring blood pressure were found to give similar results. Blood pressure and heart rate were monitored during head-up tilt to 600, graded lower body negative pressure (LBNP) to -60 mm Hg (12) , immersion of a hand in ice water for 5 min, supine leg exercise to a state of fatigue, using a bicycle ergometer, and during the intravenous administration of 2 mg of atropine. Reflexly induced changes in forearm venous tone were elicited during ice application to the forehead, the Valsalva maneuver, and deep breathing. Forearm vascular responses were determined using plethysmographic techniques (13, 14) . During combined tyraminemonoamine oxidase (MAO) inhibitor therapy, blood pressure and heart rate responses to head-up tilt, lower body negative pressure, and cold pressor test were retested. The observations of forearm vascular responses to lower body negative pressure were repeated.
Pharmacologic tests before and during tyramine-MAO inhibitor therapy were conducted. Patients were brought to the laboratory in a fasting state and during a comparable hour of the day. Forearm blood flow was measured with a mercury-in-rubber strain gauge plethysmograph (15) . Blood pressure was measured from the brachial artery using a small catheter (PE 90) and strain gauge transducer (P23Db). Anesthesia for percutaneous insertion of the catheter was placed intradermally to avoid disturbing major nerves in the forearm. It is unlikely that the catheter interfered significantly with blood flow through the forearm in these experiments because: (a) the outer diameter of the catheter, 1.27 mm, was small in comparison to the lumen diameter of. the artery; (b) smaller arteries downstream to the catheter are functionally the significant resistance vessels which regulate limb blood flow (16) ; and (c) observations of blood flow before and during treatment were made with the small catheter in the brachial artery so that conditions were comparable in the control and test conditions. Forearm vascular resistance was calculated as the ratio of mean arterial pressure (mm Hg) to forearm blood flow (ml/min/ 100 ml forearm) and is expressed in arbitrary units.
Intravenous norepinephrine was given in concentrations of 0.0375, 0.075, and 0.15 ug base/kg body weight per min; intravenous tyramine was infused in concentrations of 9, 18, and 36 ,ug base/kg per min. Doses used for intra-arterial norepinephrine and tyramine were 0.0375, 0.075, and 0.15 and 9, 18, and 36 ,g base/min, respectively. Arterial blood pressure and forearm blood flow determinations in response to norepinephrine and tyramine were performed again after 2 wk administration of the monoamine oxidase (MAO) inhibitor tranylcypromine, 60 mg/day. A 4 point parallel line bioassay was used to estimate the change in potency induced by monoamine oxidase inhibition (17) . Brachial artery blood pressure and forearm blood flow also were observed in 44 separate studies on 31 healthy normal volunteers during intraarterial administration of tyramine and norepinephrine. The doses were the same as those administered to the patients with postural hypotension.
During the period of observation in the Metabolic Research Ward by the same nurse observers, blood pressure was measured by the cuff-auscultatory method and pulse rate by radial artery palpation. Pulse rate and blood pressure levels were determined recumbent and sitting (and standing if possible) at half-hour intervals during waking hours.
After a period of 8 wk on a stable diet and activity program, the patients were placed on tranylcypromine, 60 mg/day, in 5 divided doses. After 1 wk of tranylcypromine therapy, New York State cheddar cheese, containing approximately 1.4 mg tyramine per gram of cheese, was started (18) . Cheddar cheese was taken orally at 3-hr intervals during the patients' waking hours, for a total of 60-90 g/day. The 3 hr interval between cheese servings was followed after noting that cheese administration during monoamine oxidase inhibition would usually elicit a pressor response lasting 2-3 hr. The responses to intra-arterial and intravenous infusions of norepinephrine and tyramine before and after 2 wk of tranylcypromine therapy are summarized in Table I .
RESULTS
Before MAO inhibition. Control forearm vascular resistance levels in the two patients before intra-arterial infusions of norepinephrine and tyramine were lower but within two standard deviations of the mean forearm vascular resistance levels in quiet, recumbent normal young men (Fig. 3) . During the administration of increasing concentrations of both agents a vasoconstrictor effect was noted, manifested by decreasing forearm blood flow and rising forearm vascular resistance.
During intravenous administration of norepinephrine and tyramine, mean blood pressure increased significantly in the two patients confirming the impression that vasopressor drugs were effective.
After MAO inhibition. The vasoconstrictor effect of intra-arterial norepinephrine was potentiated in patient W. L. 1-fold potentiation) .
The pressor effect of tyramine, administered intravenously, was potentiated 1 Fig. 4 . Before cheese, head-up tilt resulted in marked postural hypotension. 53 min after a 7.5 g serving of cheese, recumbent blood pressure was considerably higher. Tilting during the hypertensive effects of combination therapy also was associated with a modest decrease in blood pressure but not to levels that resulted in syncope.
Over a 9 month period of therapy, average recumbent blood pressure averaged 138/85 and sitting pressure 99/70. On this regimen the patients have been able to sit for at least 6 hr a day, and to stand. Cerebellar ataxia and weakness have prevented walking. Combination therapy was discontinued three times over the prolonged observation period, and each time blood pressure returned to pretherapy levels. Neither cheddar cheese nor tranylcypromine, when administered singly, raised blood pressure. For a few days, the patients received ephedrine sulfate, 75 mg/day, plus tranylcypromine. This combination induced a blood pressure rise similar to that observed with the cheese-tranylcypromine program. However, palpitations and tremulousness caused the patients to request discontinuation of the ephedrine.
DISCUSSION
The abnormal circulatory reflexes in the two patients studied raises the possibility of several defective mechanisms. Possible defects would include (a) impaired adrenergic vasoconstriction, (b) the presence of an abnormal vasodilator mechanism, and (c) failure of some other endocrine pressor system.
Functional impairment of the sympathetic vasomotor system is indicated by the absence of a blood pressure rise during cold pressor test, failure of reflex venoconstriction during appropriate stimuli, and in patient W. L. by the low 24 hr urinary catecholamines. The marked drop in cardiac output in W. L. during head-up tilt may similarly be attributed to impaired venoconstriction resulting in decreased venous return.
Afferent pathways appeared to be intact because blood pressure increases induced by infusions of norepinephrine or the post-tilt hypertensive phenomenon were accompanied by appropriate reflex bradycardia. Neither patient had demonstrable impairment of somatic sensory function. By exclusion, disturbances of central integrative or peripheral efferent sympathetic pathways accounted for the impaired vasoconstrictor responses in these two patients. Anatomic evidence to support autonomic failure at a preganglionic level is derived from the studies of Johnson, Lee, Oppenheimer, and Spalding in two patients clinically similar to ours (19) . A marked depletion of cells in the intermediolateral cell column of the spinal cord was found at postmortem examination. Vasoconstriction noted during intravenous and intraarterial norepinephrine infusion confirmed the presence of functional receptor sites in vascular smooth muscle. Further, the vasoconstriction observed during tyramine infusion suggested that the postganglionic sympathetic nerves contained norepinephrine. Both animal (20) and human studies (21, 22) indicate that the hemodynamic effects of tyramine are due to its ability to release norepinephrine from sympathetic nerve endings.
Another mechanism which may have contributed to the severe postural hypotension is the presence of an abnormal vasodilator response. During lower body negative pressure application, and on another occasion, during head-up tilt at right heart catheterization, patient W. L. demonstrated this unexpected circulatory response. The decrease in forearm vascular resistance during LBNP and the unchanging systemic vascular resistance during head-up tilt, at a time when blood pressure was falling markedly, would indicate active vasodilatation. This phenomenon has been observed in patients with postural hypotension by others (2, 23) . Abboud and Eckstein demonstrated that similar vasodilatation induced in normal subjects after treatment with guanethidine can be partially blocked by atropine (24) . Alternatively, autoregulation of blood flow in association with a significant decrease in cardiac output could account for a decrease in forearm vascular resistance or failure to increase systemic vascular resistance during LBNP and head-up tilt. The mechanism of the vasodilator response in W. L. was not ascertained. Interestingly, the second patient C. H. who was less severely afflicted, did not demonstrate a vasodilator response to lower body negative pressure maneuver.
In the presence of combination therapy, LBNP in patient W. L. was associated with an increase in forearm vascular resistance from a control level of 36.2 U to 60.1 U at -60 mm Hg. Therefore, the vasodilatory response in this patient during LBNP before therapy was not observed during tyramine-tranylcypromine administration. In both patients, cold pressor test repeated during the combination therapy did not produce vasoconstriction.
In normal subjects, the elevation in plasma renin activity associated with head-up tilt returns to pretilt levels within 30 min (25) . During a tilting maneuver which did not provoke a marked hypertensive response, patient W. L.'s plasma renin response was normal. However, when an exaggerated blood pressure rise was noted during another tilting procedure, plasma renin activity was elevated for more than 49 min after return to recumbency. From these observations, it appears that the renin-angiotensin system is not responsible for the postural hypotension, but may be related to the posttilt pressor response. In contrast, Gordon, Kuchel, Liddle, and Island, studying a patient with amyloidosis and orthostatic hypotension, noted a failure of plasma renin activity to increase with upright posture (26) .
Based upon the observation that intravenous and intraarterial tyramine could produce a pressor or vasoconstrictor response, it was assumed that the postganglionic nerve fibers contained norepinephrine. Patients receiving monoamine oxidase inhibitor drugs have experienced hypertensive crises after ingestion of foods containing tyramine, due to release of an increased amount of norepinephrine (27) . A treatment regimen of a monoamine oxidase inhibitor and tyramine was cautiously begun, in an effort to convert a potentially dangerous side effect into a clinically useful therapy.
Although substantial clinical improvement occurred, one major difficulty was encountered. Pressor response to each serving of cheese was frequently erratic, resulting in considerable fluctuation in blood pressure. No dangerous elevations in blood pressure were noted with the dosages employed. We are presently unable to determine the etiology of the pressure fluctuation.
Blood pressure elevation was generally related to the cheese dosage. Combination therapy did not have any effect on the patients' incoordination, bladder and bowel dysfunction, or anhydrosis.
Pharmacologic testing with intra-arterial infusions demonstrated in W. L. that 3.7 times more tyramine was required before tranylcypromine administration than after 2 wk of this agent in order to produce similar increases in forearm vascular resistance. This implies potentiation of its action which might be due to interference with metabolism of the infused tyramine or due to altered metabolism of endogenous norepinephrine released by tyramine. Further, the effects of intra-arterial norepinephrine and tyramine were potentiated to the same degree by monoamine oxidase inhibition. This is indicated by the fact that 4.1 times more norepinephrine was required before tranylcypromine than after treatment to give equivalent increases in forearm vascular resistance. Thus, in W. L. there appears to have been a significant inhibition of MAO-mediated intraneuronal deamination of norepinephrine. However, in C. H. treatment with tranylcypromine had no demonstrable influence on the vascular effects of either intra-arterial tyramine or norepinephrine.
Experimental evidence suggests that another mechanism by which MAO inhibitors enhance the pressor effect of tyramine is by retarding its metabolism in the liver (28) . However, intravenckis tyramine was not augmented by tranylcypromine in either patient; this is contrasted with the marked hypertensive response produced by oral cheese (tyramine) during monoamine oxidase inhibition. Before monoamine oxidase inhibitor therapy, oral cheese had no pressor effect. The sustained hypertension produced by the tranylcypromine-cheese combination implies that tyramine given orally was potentiated by MAO enzyme inhibition. It was therefore unexpected that intravenous tyramine was not potentiated by MAO inhibition. It can only be conjectured that tranylcypromine acted on an important source of monoamine oxidase in the intestine or portal circulation which was not accessible to tyramine administered intravenously.
The recent report by Seller, in which a tranylcypromine-hydroxyamphetamine therapeutic program was of significant value in treating another patient with idiopathic postural hypotension should be noted (29) . It is important to recognize that therapy with a monoamine oxidase-cheddar cheese regimen may potentially cause dangerous elevations in blood pressure. Unexpected elevation in blood pressure could result, in part, from variation in the concentration of tyramine per gram of cheese. Caution should be exercised in initiating the program in severe cases of idiopathic postural hypotension. More conventional treatment with mineralocorticoids, high salt intake, and pressure garments should be employed first. It is important to recognize that some patients with postural hypotension may have autonomic defects involving a reduction in vascular stores of norepinephrine and thereby decreased responsiveness to tyramine (23) . The effectiveness of combined monoamine oxidase inhibition and tyramine in patients other than those with the Shy-Drager syndrome remains to be demonstrated.
